However, according to the European Malignant Hyperthermia Group (https://emhg.org/genetics/, accessed on 16 January 2022), currently, only 48 reported RYR1 mutations and two CACNA1S mutations have proven pathogenic according to those stringent criteria [9,10]. The gene discussed is RYR1; the disease is Malignant hyperthermia.